Dr. Martens have achieved double digit sales and EBITDA growth this year.  It has described it as a fantastic year. 

In the year until 31st March, revenue was up by 20% totalling to £348.6 million, with EBITDA growing by 30% to £50 million.

Dr. Martens have continued to invest by opening 25 new stores in key locations.  This includes nine in the UK, seven across Europe, three in New York and three in Japan.  The retailer had a portfolio of 94 stores at the year end.

Paul Mason, chairman of Dr. Martens, said: “This has been a fantastic year for Dr. Martens. We’ve delivered another set of strong results with broad-based growth across all regions and channels and double-digit revenue and EBITDA performances. This, in the context of the wider macroeconomic uncertainty that exists in a few of our key markets, is testament to both the strength of our brand, our heritage and consumer proposition and the execution of our strategy.”